A research team at Lund University in Sweden has discovered a certain type of cell—foam cells—in patients with the aggressive ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

Glioblastoma is the most common and deadliest form of brain cancer. Patients face a bleak prognosis—the average survival ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

Researchers have identified potential drug targets in glioblastoma cancer stem cells, providing a new approach to treat this ...

A team led by researchers at the University of Toronto has uncovered new targets that could be the key to effectively ...

Phase 3 trial results showed that adding veliparib to temozolomide did not significantly improve overall or progression-free survival in newly diagnosed, MGMT-hypermethylated glioblastoma.

The initial trio of patients with glioblastoma have begun treatment with ropidoxuridine in a phase 2 clinical trial, ...

New cancer trial is a ‘lifeline’, says 62-year-old Paul Read who would’ve had less than a year to live due to aggressive ...

How the Scars of Demolished Brain Tumors Seed Relapse Sep. 9, 2024 — A study has discovered that recurrent tumors of the aggressive brain cancer glioblastoma multiforme (GBM) grow out of the ...

CureVac (CVAC) announced that new and updated data will be shared in two oral presentations and four posters at the 12th International mRNA ...

In July, the company announced results from the Phase II/III clinical trial, GBM-AGILE, in which newly diagnosed unmethylated patients with glioblastoma treated with paxalisib showed clinically ...